Verapamil Hydrochloride Injection, Solution
Product Images NDC 25021-312

2 FDA label images from Sagent Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 25021-312). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (Ver02 0000 01)

Structural Formula (Ver02 0000 01)
Chemical structure diagram of Verapamil Hydrochloride showing its molecular arrangement including benzene rings, methoxy groups, cyano group, and hydrochloride component.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Ver02 0000 02)

Package Label – Principal Display Panel – Vial Label (Ver02 0000 02)
Label for Verapamil Hydrochloride Injection USP, 5 mg per 2 mL (2.5 mg per mL) intravenous solution. Single-dose vial containing 2 mL. Label indicates it is manufactured for Sagent Pharmaceuticals, made in India, and includes NDC 25021-312-02. Instructions to protect from light and discard unused portion are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.